BioPharma’s Pride & Prejudice
How to break down the data management and data exchange firewalls between analytical development and process development scientists
In this podcast, Michael Barnes, IDBS Lead Solutions Consultant and former process development scientist at Pfizer, and Shirlee Wallingford, an analytical development scientist with 17+ years’ experience at Allergen/Abbvie, compare perspectives and share experiences in this friendly debate between these 2 proximal yet traditionally disjointed groups.
Hear Michael and Shirley talk about the common roadblocks they faced and their tips for improving data and process exchange between the separate departments of analytical development and process development.
They discuss how the current process of information exchange between these groups leads to “hero or zero” statuses, a lack of trust, and an abundance of emails and accessory files. As it stands today, the manner in which these processes and data are stored requires users, managers, and others to go to great lengths to find relevant data and documentation and sample locations; and it is difficult to link the data pre- or post-any sample exchanges. It can be quite common for R&D to have, in effect, three siloed data stores: a sample system (for example a LIMS), an ELN (Electronic Lab Notebook), and the data which resides within instruments/associated computers. Frequently, ELN systems are only used as file repositories.
With IDBS Polar, the unification of process capture, inventory management, and instrument data within a single digital backbone, makes the data easily searchable and accessible. Collectively, this allows users to drive insights across time and across assays, groups, and even companies to the benefit of all scientists working across the BioPharma lifecycle.